Viewing Study NCT01896193


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-02-25 @ 7:39 AM
Study NCT ID: NCT01896193
Status: COMPLETED
Last Update Posted: 2015-05-29
First Post: 2013-07-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection
Sponsor: Gilead Sciences
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GS-US-334-0119
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators